Clinical trial
A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives
NCT00301587 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Withdrawn
Key facts
| NCT number | NCT00301587 |
|---|---|
| Title | A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives |
| Official title | A Randomized, Double-Blind, Two-Part, Parallel-Group, Comparative Study to Evaluate Blood Folate Levels in Women Taking an Oral Contraceptive With and Without Folic Acid |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neural Tube Defects, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nervous System Malformations |
| Intervention type | Drug |
| Interventions | Norgestimate-ethinyl estradiol, with or without folic acid |
| Enrollment | 0 |
| Completion | Dec 1, 2004 |
| First posted | Mar 13, 2006 |
| Last update posted | Sep 20, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: